nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00525	1	CrCbGaD
Methylphenidate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.000326	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000323	CcSEcCtD
Methylphenidate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000323	CcSEcCtD
Methylphenidate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000321	0.000323	CcSEcCtD
Methylphenidate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000323	CcSEcCtD
Methylphenidate—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000321	CcSEcCtD
Methylphenidate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000321	CcSEcCtD
Methylphenidate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000319	0.000321	CcSEcCtD
Methylphenidate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000318	0.00032	CcSEcCtD
Methylphenidate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000319	CcSEcCtD
Methylphenidate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000317	0.000318	CcSEcCtD
Methylphenidate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000318	CcSEcCtD
Methylphenidate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Methylphenidate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Methylphenidate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Methylphenidate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Methylphenidate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000315	CcSEcCtD
Methylphenidate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000315	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000313	CcSEcCtD
Methylphenidate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.000313	CcSEcCtD
Methylphenidate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000311	0.000313	CcSEcCtD
Methylphenidate—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000311	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000309	0.00031	CcSEcCtD
Methylphenidate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00031	CcSEcCtD
Methylphenidate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000308	0.00031	CcSEcCtD
Methylphenidate—Pain—Etoposide—peripheral nervous system neoplasm	0.000306	0.000307	CcSEcCtD
Methylphenidate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000306	0.000307	CcSEcCtD
Methylphenidate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000307	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000305	CcSEcCtD
Methylphenidate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.000305	CcSEcCtD
Methylphenidate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000302	0.000304	CcSEcCtD
Methylphenidate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000303	CcSEcCtD
Methylphenidate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000301	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000299	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000299	CcSEcCtD
Methylphenidate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000298	CcSEcCtD
Methylphenidate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000298	CcSEcCtD
Methylphenidate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000297	CcSEcCtD
Methylphenidate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000296	CcSEcCtD
Methylphenidate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000295	0.000296	CcSEcCtD
Methylphenidate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.000295	CcSEcCtD
Methylphenidate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000294	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000292	0.000294	CcSEcCtD
Methylphenidate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000292	0.000293	CcSEcCtD
Methylphenidate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000293	CcSEcCtD
Methylphenidate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000292	CcSEcCtD
Methylphenidate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000292	CcSEcCtD
Methylphenidate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000292	CcSEcCtD
Methylphenidate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00029	CcSEcCtD
Methylphenidate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00029	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00029	CcSEcCtD
Methylphenidate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000289	CcSEcCtD
Methylphenidate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000289	CcSEcCtD
Methylphenidate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.000289	CcSEcCtD
Methylphenidate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000284	0.000286	CcSEcCtD
Methylphenidate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000285	CcSEcCtD
Methylphenidate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000284	CcSEcCtD
Methylphenidate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000283	0.000284	CcSEcCtD
Methylphenidate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000283	0.000284	CcSEcCtD
Methylphenidate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000284	CcSEcCtD
Methylphenidate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000284	CcSEcCtD
Methylphenidate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000281	0.000282	CcSEcCtD
Methylphenidate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000282	CcSEcCtD
Methylphenidate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000282	CcSEcCtD
Methylphenidate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.00028	CcSEcCtD
Methylphenidate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00028	CcSEcCtD
Methylphenidate—Rash—Vincristine—peripheral nervous system neoplasm	0.000278	0.00028	CcSEcCtD
Methylphenidate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000278	0.00028	CcSEcCtD
Methylphenidate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000279	CcSEcCtD
Methylphenidate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000279	CcSEcCtD
Methylphenidate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000278	CcSEcCtD
Methylphenidate—Headache—Vincristine—peripheral nervous system neoplasm	0.000277	0.000278	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000276	CcSEcCtD
Methylphenidate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000276	CcSEcCtD
Methylphenidate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000274	CcSEcCtD
Methylphenidate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.000274	CcSEcCtD
Methylphenidate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000273	CcSEcCtD
Methylphenidate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000268	CcSEcCtD
Methylphenidate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000268	CcSEcCtD
Methylphenidate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000267	CcSEcCtD
Methylphenidate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000265	CcSEcCtD
Methylphenidate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000263	0.000265	CcSEcCtD
Methylphenidate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000264	CcSEcCtD
Methylphenidate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000262	0.000264	CcSEcCtD
Methylphenidate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000263	CcSEcCtD
Methylphenidate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000263	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000263	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000262	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00026	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000259	CcSEcCtD
Methylphenidate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000257	0.000258	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000258	CcSEcCtD
Methylphenidate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000257	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000257	CcSEcCtD
Methylphenidate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000256	CcSEcCtD
Methylphenidate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000256	CcSEcCtD
Methylphenidate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000255	CcSEcCtD
Methylphenidate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000253	0.000254	CcSEcCtD
Methylphenidate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000253	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000253	CcSEcCtD
Methylphenidate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000251	CcSEcCtD
Methylphenidate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00025	CcSEcCtD
Methylphenidate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000248	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000248	CcSEcCtD
Methylphenidate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000247	CcSEcCtD
Methylphenidate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000247	CcSEcCtD
Methylphenidate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000247	CcSEcCtD
Methylphenidate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000247	CcSEcCtD
Methylphenidate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000245	0.000246	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000245	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000244	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000244	CcSEcCtD
Methylphenidate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000242	CcSEcCtD
Methylphenidate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00024	CcSEcCtD
Methylphenidate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000239	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000238	CcSEcCtD
Methylphenidate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000236	0.000238	CcSEcCtD
Methylphenidate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000237	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000237	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000237	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000235	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000234	CcSEcCtD
Methylphenidate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000232	0.000233	CcSEcCtD
Methylphenidate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000233	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000232	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00023	CcSEcCtD
Methylphenidate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000229	CcSEcCtD
Methylphenidate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000227	0.000229	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000228	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000228	CcSEcCtD
Methylphenidate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000228	CcSEcCtD
Methylphenidate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000227	CcSEcCtD
Methylphenidate—Rash—Etoposide—peripheral nervous system neoplasm	0.000225	0.000227	CcSEcCtD
Methylphenidate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000225	0.000226	CcSEcCtD
Methylphenidate—Headache—Etoposide—peripheral nervous system neoplasm	0.000224	0.000225	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000224	CcSEcCtD
Methylphenidate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000223	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000222	CcSEcCtD
Methylphenidate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000222	CcSEcCtD
Methylphenidate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000221	CcSEcCtD
Methylphenidate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000221	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000221	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00022	CcSEcCtD
Methylphenidate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000218	CcSEcCtD
Methylphenidate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000217	CcSEcCtD
Methylphenidate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000215	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000215	CcSEcCtD
Methylphenidate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000214	CcSEcCtD
Methylphenidate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000212	0.000214	CcSEcCtD
Methylphenidate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000213	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000212	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000211	CcSEcCtD
Methylphenidate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00021	CcSEcCtD
Methylphenidate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00021	CcSEcCtD
Methylphenidate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00021	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00021	CcSEcCtD
Methylphenidate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000209	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000209	CcSEcCtD
Methylphenidate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000208	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000206	CcSEcCtD
Methylphenidate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000206	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000205	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000205	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000205	CcSEcCtD
Methylphenidate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000203	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000202	CcSEcCtD
Methylphenidate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000202	CcSEcCtD
Methylphenidate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000202	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000201	CcSEcCtD
Methylphenidate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000199	0.0002	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000199	CcSEcCtD
Methylphenidate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000198	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000198	CcSEcCtD
Methylphenidate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000198	CcSEcCtD
Methylphenidate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000197	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000197	CcSEcCtD
Methylphenidate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000197	CcSEcCtD
Methylphenidate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000196	CcSEcCtD
Methylphenidate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000195	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000195	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000195	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000195	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000194	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000193	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000192	CcSEcCtD
Methylphenidate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000192	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00019	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000188	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000186	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000186	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000185	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000184	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000183	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000183	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000183	CcSEcCtD
Methylphenidate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000182	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000182	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000181	CcSEcCtD
Methylphenidate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000181	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00018	CcSEcCtD
Methylphenidate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00018	CcSEcCtD
Methylphenidate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000179	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000178	CcSEcCtD
Methylphenidate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000177	CcSEcCtD
Methylphenidate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000175	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000174	CcSEcCtD
Methylphenidate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000174	CcSEcCtD
Methylphenidate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000172	CcSEcCtD
Methylphenidate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000172	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00017	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000169	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000166	CcSEcCtD
Methylphenidate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000166	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000166	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000165	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000164	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000162	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000161	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000161	CcSEcCtD
Methylphenidate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00016	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000159	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000159	CcSEcCtD
Methylphenidate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000159	CcSEcCtD
Methylphenidate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000159	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000154	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000152	CcSEcCtD
Methylphenidate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000148	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000147	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000147	CcSEcCtD
Methylphenidate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000145	CcSEcCtD
Methylphenidate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000143	CcSEcCtD
Methylphenidate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000138	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000137	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000134	CcSEcCtD
Methylphenidate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000133	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000132	CcSEcCtD
Methylphenidate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000128	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000128	CcSEcCtD
Methylphenidate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000127	CcSEcCtD
Methylphenidate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000127	CcSEcCtD
Methylphenidate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000126	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000123	CcSEcCtD
Methylphenidate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00012	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000119	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000118	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000117	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000117	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000111	CcSEcCtD
